Commonwealth Equity Services’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Commonwealth Equity Services’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,261	Closed	-$32K	–	3837
2022 Q3	$32K	Buy	50,261 +1,885	+4%	+$2.78K	﹤0.01%	3529
2022 Q2	$117K	Sell	48,376 -2,308	-5%	-$6.41K	﹤0.01%	3338
2022 Q1	$204K	Buy	50,684 +13,462	+36%	+$73.8K	﹤0.01%	3325
2021 Q4	$298K	Buy	37,222 +7,421	+25%	+$87K	﹤0.01%	2978
2021 Q3	$575K	Buy	29,801 +12,778	+75%	+$223K	﹤0.01%	2372
2021 Q2	$234K	Buy	17,023 +5,029	+42%	+$59.6K	﹤0.01%	3133
2021 Q1	$108K	Buy	+11,994	New	+$87.7K	﹤0.01%	3253

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SGCA

Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Commonwealth Equity Services's PLXP Position: Q4 2022 in Review

Commonwealth Equity Services sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 50,261 shares — an estimated $32K sold.

Commonwealth Equity Services first reported a position in PLXP in Q1 2021 and held it in 7 quarters. The position peaked at $575K in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

Commonwealth Equity Services reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Commonwealth Equity Services sold 50,261 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $32K.
Commonwealth Equity Services first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Commonwealth Equity Services's PLx Pharma Inc. Common Stock position peaked at $575K in Q3 2021.
41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.